DERIVATIVE AND HEDGING INSTRUMENTS (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Derivative Instruments and Hedging Activities Disclosure [Abstract] |
|
| Schedule of Notional Amount of Derivatives Instruments |
The following presents the notional amount of derivative instruments (in thousands): | | | | | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | Derivatives designated as cash flow hedges: | | | | | | Denominated in U.S. Dollars | | $ | 930,000 | | | $ | 930,000 | | | Denominated in Canadian Dollars | | $ | 150,000 | | | $ | 150,000 | | | | | | | | | | | | | Financial instruments designated as net investment hedges: | | | | | | Denominated in Canadian Dollars | | $ | 184,800 | | | $ | 183,700 | | | | | | | | | | | |
|
| Schedule of Derivative and Financial Instruments Designated as Hedging Instruments |
The following is a summary of the derivative and financial instruments designated as hedging instruments held by the Company (dollars in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Count as of June 30, 2026 | | Fair Value as of | | Maturity Dates as of June 30, 2026 | | | | Type | | Designation | | | June 30, 2026 | | December 31, 2025 | | | Balance Sheet Location | | Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | Interest rate swaps | | Cash flow | | 11 | | | $ | 14,724 | | | $ | 3,378 | | | 2028 - 2030 | | Accounts receivable, prepaid expenses and other assets, net | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities: | | | | | | | | | | | | | | Interest rate swaps | | Cash flow | | — | | | $ | — | | | $ | 1,281 | | | — | | Accounts payable and accrued liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | CAD borrowings under Revolving Credit Facility | | Net investment | | 1 | | | 24,475 | | | 24,584 | | | 2027 | | Revolving credit facility | | CAD Term Loan | | Net investment | | 1 | | | 105,495 | | | 109,425 | | | 2028 | | Term loans, net | | | | | | | $ | 129,970 | | | $ | 135,290 | | | | | |
|
| Schedule of Effect of Derivative Financial Instruments on the Condensed Consolidated Statements of (Loss) Income and Condensed Consolidated Statements of Equity |
The following presents the effect of the Company’s derivative and financial instruments designated as hedging instruments on the consolidated statements of (loss) income and the consolidated statements of equity (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gain (Loss) Recognized in Other Comprehensive Income (Loss) | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | Cash Flow Hedges: | | | | | | | | | | Interest rate products | | $ | 8,117 | | | $ | (2,528) | | | $ | 14,803 | | | $ | (7,196) | | | Net Investment Hedges: | | | | | | | | | | Foreign currency products | | — | | | (1,586) | | | — | | | (1,418) | | | CAD borrowings under Revolving Credit Facility | | 505 | | | (330) | | | 880 | | | (558) | | | CAD Term Loan | | 2,175 | | | (5,355) | | | 3,930 | | | (5,490) | | | | $ | 10,797 | | | $ | (9,799) | | | $ | 19,613 | | | $ | (14,662) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gain Reclassified from Accumulated Other Comprehensive Income (Loss) into Income | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | Income Statement Location | | 2026 | | 2025 | | 2026 | | 2025 | | Cash Flow Hedges: | | | | | | | | | | | | Interest rate products | | Interest expense | | $ | 724 | | | $ | 1,323 | | | $ | 1,531 | | | $ | 2,712 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Schedule of Gross Presentation, Effects of Offsetting, and Net Presentation of Derivatives - Assets |
The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of June 30, 2026 | | | Gross Amounts of Recognized Assets / Liabilities | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Assets / Liabilities Presented in the Balance Sheet | | Gross Amounts Not Offset in the Balance Sheet | | | | | | | | Financial Instruments | | Cash Collateral Received | | Net Amount | | Offsetting Assets: | | | | | | | | | | | | | | Derivatives | | $ | 14,724 | | | $ | — | | | $ | 14,724 | | | $ | — | | | $ | — | | | $ | 14,724 | | | Offsetting Liabilities: | | | | | | | | | | | | | | Derivatives | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | Gross Amounts of Recognized Assets / Liabilities | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Assets / Liabilities Presented in the Balance Sheet | | Gross Amounts Not Offset in the Balance Sheet | | | | | | | | Financial Instruments | | Cash Collateral Received | | Net Amount | | Offsetting Assets: | | | | | | | | | | | | | | Derivatives | | $ | 3,378 | | | $ | — | | | $ | 3,378 | | | $ | (212) | | | $ | — | | | $ | 3,166 | | | Offsetting Liabilities: | | | | | | | | | | | | | | Derivatives | | $ | 1,281 | | | $ | — | | | $ | 1,281 | | | $ | (212) | | | $ | — | | | $ | 1,069 | |
|
| Schedule of Gross Presentation, Effects of Offsetting, and Net Presentation of Derivatives - Liabilities |
The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of June 30, 2026 | | | Gross Amounts of Recognized Assets / Liabilities | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Assets / Liabilities Presented in the Balance Sheet | | Gross Amounts Not Offset in the Balance Sheet | | | | | | | | Financial Instruments | | Cash Collateral Received | | Net Amount | | Offsetting Assets: | | | | | | | | | | | | | | Derivatives | | $ | 14,724 | | | $ | — | | | $ | 14,724 | | | $ | — | | | $ | — | | | $ | 14,724 | | | Offsetting Liabilities: | | | | | | | | | | | | | | Derivatives | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | Gross Amounts of Recognized Assets / Liabilities | | Gross Amounts Offset in the Balance Sheet | | Net Amounts of Assets / Liabilities Presented in the Balance Sheet | | Gross Amounts Not Offset in the Balance Sheet | | | | | | | | Financial Instruments | | Cash Collateral Received | | Net Amount | | Offsetting Assets: | | | | | | | | | | | | | | Derivatives | | $ | 3,378 | | | $ | — | | | $ | 3,378 | | | $ | (212) | | | $ | — | | | $ | 3,166 | | | Offsetting Liabilities: | | | | | | | | | | | | | | Derivatives | | $ | 1,281 | | | $ | — | | | $ | 1,281 | | | $ | (212) | | | $ | — | | | $ | 1,069 | |
|